Homestead Advisers Corp
Source: SEC Form 13F · as of Mar 2026Homestead Advisers Corp holds 12 biotech & pharma companies tracked by BioSniper, totaling $423.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$423.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 439,401 | $95.3M |
| RPRXRoyalty Pharma plc | 1,653,042 | $78.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 264,472 | $71.2M |
| GEHCGE HealthCare Technologies Inc. | 890,788 | $63.1M |
| ABTABBOTT LABORATORIES | 519,571 | $53.3M |
| MRKMerck & Co., Inc. | 210,577 | $25.3M |
| BMYBRISTOL MYERS SQUIBB CO | 370,021 | $22.4M |
| GMEDGlobus Medical Inc. | 76,325 | $6.6M |
| LNTHLantheus Holdings, Inc. | 37,900 | $2.9M |
| MEDPMedpace Holdings Inc. | 5,750 | $2.8M |
| PRAXPraxis Precision Medicines, Inc. | 3,300 | $1.1M |
| BBIOBridgeBio Pharma, Inc. | 5,900 | $438K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.